A clinical trial involving plasma donations from recovered COVID-19 patients has it’s first donor.
Canadian Blood Services is a part of CONCOR, a national clinical trial to test the safety and effectiveness of COVID-19 convalescent plasma as a possible treatment for those with to with the virus.
The first donation was collected in Vancouver last week from a longtime donor.
“I’m delighted to be able to help out a really good cause. I have been an active blood donor for 15 years. I’m pleased my unfortunate situation can help somebody else. I think I’m doing a little bit of good out of all this.” says Jerry Glubisz, Canadian Blood Services’ first COVID-19 convalescent plasma donor.
Canadian Blood Services is recruiting potential convalescent plasma donors across the country through an online registry.
Donors can contribute at 11 centres in Canada including Vancouver, Calgary, Winnipeg, Toronto and Halifax.
Participants must be 67-years-old or younger, have previously confirmed positive for COVID-19 by a lab test and be fully recovered from the virus and symptom free for at least 28 days.
